These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 17533740)

  • 1. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening of differential expression genes between primary breast cancer and its lymph node metastasis using single primer amplification of cDNA for microarray].
    Hao XS; Feng YM; Zhang L; Li XQ; Niu Y; Xiao CH; Sun BC
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):385-90. PubMed ID: 15854527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
    Feng Y; Sun B; Li X; Zhang L; Niu Y; Xiao C; Ning L; Fang Z; Wang Y; Zhang L; Cheng J; Zhang W; Hao X
    Breast Cancer Res Treat; 2007 Jul; 103(3):319-29. PubMed ID: 17123152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis.
    Lähdesmäki H; Hao X; Sun B; Hu L; Yli-Harja O; Shmulevich I; Zhang W
    Int J Oncol; 2004 Jun; 24(6):1589-96. PubMed ID: 15138604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
    Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
    Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
    Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
    Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma.
    Makretsov NA; Huntsman DG; Nielsen TO; Yorida E; Peacock M; Cheang MC; Dunn SE; Hayes M; van de Rijn M; Bajdik C; Gilks CB
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6143-51. PubMed ID: 15448001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
    Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; Shindoh G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Fujiwara Y; Shirata K; Nishimura N; Miyamoto M; Okushiba S; Kondo S; Hamada J; Katoh H; Yoshiki T; Moriuchi T
    J Surg Res; 2004 Nov; 122(1):61-9. PubMed ID: 15522316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of breast cancer patients by gene expression profiling.
    Ahr A; Holtrich U; Solbach C; Scharl A; Strebhardt K; Karn T; Kaufmann M
    J Pathol; 2001 Oct; 195(3):312-20. PubMed ID: 11673828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a transcriptional signature of breast cancer.
    Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
    Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
    Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
    Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.